Literature DB >> 23845896

The Slug Mucosal Irritation (SMI) assay: a tool for the evaluation of nasal discomfort.

Joke Lenoir1, Claus Bachert, Jean-Paul Remon, Els Adriaens.   

Abstract

In this research project, the Slug Mucosal Irritation (SMI) assay was applied to predict nasal discomfort, investigating the correlation between responses in slugs and humans. Several SMI experiments and a Human Nose Irritation Test (HNIT) were performed with five NaCl solutions (0.4%, 1.3%, 2.6%, 5.4% and 10.4%) and two benzalkonium chloride solutions (BAC 0.02% and BAC 0.05%). In the HNIT, subjective evaluation of clinical discomfort was performed by 24 participants at several time points. Analyzes reveal that (1) a significant positive association existed between immediate stinging reaction reported by the participants and the mean total mucus production of the slugs (Spearman's Rank correlation=0.963, p<0.001); (2) NaCl 0.4% was best tolerated in both tests; (3) a concentration-response effect was observed for NaCl and BAC solutions; (4) NaCl 10.4% induced the highest mucus production in the slugs and received higher sting scores for immediate discomfort in the HNIT; (5) stinging sensations decreased rapidly in time and (6) based on these results a new classification prediction model for nasal applications was established. In conclusion, the SMI assay is a promising evaluation method for clinical nasal discomfort. Screening (prototype) formulations with this assay allows formula optimization prior to a clinical trial.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Benzalkonium chloride; Human Nose Irritation Test; NaCl; Nasal discomfort; Slug Mucosal Irritation assay

Mesh:

Substances:

Year:  2013        PMID: 23845896     DOI: 10.1016/j.tiv.2013.06.018

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  4 in total

1.  Potential Mucosal Irritation Discrimination of Surface Disinfectants Employed against SARS-CoV-2 by Limacus flavus Slug Mucosal Irritation Assay.

Authors:  Marco Alfio Cutuli; Antonio Guarnieri; Laura Pietrangelo; Irene Magnifico; Noemi Venditti; Laura Recchia; Katia Mangano; Ferdinando Nicoletti; Roberto Di Marco; Giulio Petronio Petronio
Journal:  Biomedicines       Date:  2021-04-14

2.  Preliminary studies on validation of calu-3 cell line as a model for screening respiratory mucosa irritation and toxicity.

Authors:  Chibueze Ihekwereme; Charles Esimone; Di Shao; Remigius U Agu
Journal:  Pharmaceutics       Date:  2014-06-13       Impact factor: 6.321

3.  Nasal Powder Formulations: In-Vitro Characterisation of the Impact of Powders on Nasal Residence Time and Sensory Effects.

Authors:  Marie Trenkel; Regina Scherließ
Journal:  Pharmaceutics       Date:  2021-03-13       Impact factor: 6.321

4.  A comparison of three mucus-secreting airway cell lines (Calu-3, SPOC1 and UNCN3T) for use as biopharmaceutical models of the nose and lung.

Authors:  Diane F Lee; Michael I Lethem; Alison B Lansley
Journal:  Eur J Pharm Biopharm       Date:  2021-07-29       Impact factor: 5.571

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.